Pacific Biosciences is trading 5% down at $1.33 on light, news-less trading.
- The move appears to be driven by idiosyncratic volatility following recent declines, as there are no fresh company-specific headlines or sector shocks this morning.
- Broader market indices are currently trading roughly flat to slightly mixed, suggesting the downward pressure is isolated to the stock rather than a macro catalyst.